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To assess the relationship between chronic bronchitis and obstructive sleep apnoea, a postal survey was 
performed. A postal questionnaire was sent to 523 subjects identified as having chronic bronchitis or 
long-standing cough and sputum production in the Obstructive Lung Disease in Northern Sweden 
Study I (OLIN I). In 1986-88, all 6610 adults born in 1919-20, 1934-35 and 1949-50 living in 
representative areas in Northern Sweden were screened for airway diseases according to different 
methods. A random sample of healthy adults identified in the screening were chosen as references 
(n= 625). Subjects were asked about a variety of airway symptoms, smoking habits and symptoms related 
to obstructive sleep apnoea syndrome (OSAS). 
In the bronchitic group, 20% did not report bronchitic symptoms in the present study, and 26% of the 
formerly healthy reference group reported at least one bronchitic symptom in the present study. Snoring, 
apnoea and liability to ‘nod off’ during activity were much more common in the bronchitic group in both 
men and women, and most common in men, as expected. Snoring was reported by 29% of the men in the 
bronchitic group and by 14% in the reference group. In women, the corresponding figures were 14 and 
8%, respectively, and for apnoea, the figures were 25 W. 11% in men and 6 vs. 4% in women. 
The prevalence of OSAS symptoms was similar in subjects with attacks of breathlessness, long- 
standing cough, sputum production and recurrent wheezing. Bronchitic symptoms may influence quality 
of sleep and contribute to daytime tiredness, but this does not fully explain the high prevalence of snoring 
and apnoea reported by subjects in this cohort. This study indicates a positive correlation between 
chronic bronchitis and OSAS, but sleep studies are required to confirm this. 
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Introduction 
Studies have shown that subjects with chronic 
obstructive pulmonary disease (COPD) or 
asthma frequently suffer from various types of 
sleep disorders (l-4). Concomitant COPD and 
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the sleep apnoea syndrome, overlap syndrome, is 
known to result in a more severe disease with 
pronounced and prolonged oxygen desaturation 
during sleep and an increased risk of pulmonary 
hypertension (5-9). 
In a general population, the prevalence of 
habitual snoring has been estimated at about 
ll-15% in men (10-13). It has been suggested 
that snoring and other symptoms related to the 
obstructive sleep apnoea syndrome (OSAS) oc- 
cur more frequently in patients with obstructive 
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TABLE 1. Invited subjects and participants in the bronchitic and the reference groups ^ 
Age cohort 
Y 
1919-20 1934-35 1949-50 
QL (71-72 years) (5657 years) (41-42 years) All 
c-. 
MFMFMFM F Total 
Bronchitic group 
Invited 113 71 129 73 82 55 324 199 523 
Drop outs 12 7 14 10 19 11 45 28 73 
Participants 101 64 115 63 63 44 279 171 450 
(%I (8% PO) (84) (86) (77) (80) (86) (86) (86) 
Smoking habits (%) 
Non-smokers (18) (57) (12) (24) (13) (14) (14) (33) (21) 
Ex-smokers (48) (18) (36) (13) (18) (9) (36) (14) (28) 
Smokers (35) (26) (52) (64) (70) (77) (50) (53) (51) 
Reference group 
Invited 174 98 135 69 97 52 406 219 625 
Drop outs 18 12 21 12 22 8 64 32 96 
Participants 153 86 114 57 75 44 342 187 529 
W) W-9 (88) (84) (82) (77) (85) (84) (85) (85) 
Smoking habits (%) 
Non-smokers (39) (77) (32) (58) (41) (52) (37) (65) (47) 
Ex-smokers (43) (13) (41) (19) (27) (18) (39) (16) (31) 
Smokers (18) (11) (27) (23) (32) (30) (24) (19) (22) 
lung diseases such as COPD and asthma, but it is 
not known if the prevalence of OSAS is higher 
among those with obstructive lung disease 
compared with a healthy population (14,15). 
The epidemiological Obstructive Lung Dis- 
ease in Northern Sweden study (OLIN) started 
as a cross-sectional study in order to estimate 
the prevalence of obstructive airway diseases 
(16,17), and to be the starting point for longi- 
tudinal studies (18). More severe conditions such 
as respiratory insufficiency and overlap syn- 
drome are currently under study. 
The aim of the present paper is to report the 
occurrence of symptoms related to OSAS in sub- 
jects with chronic bronchitis, various chronic res- 
piratory symptoms and no respiratory symptoms. 
Material and Methods 
STUDY POPULATION 
The study population consisted of two groups - 
one bronchitic and one non-bronchitic, non- 
asthmatic - according to the OLIN prevalence 
study performed in 1986-87 (17,18). The bron- 
chitic group consisted of 523 subjects after exclu- 
sion of 19 subjects who could not be traced and 
33 patients who had died. Of these 523 subjects, 
23 had chronic bronchitis and concomitant 
reversible airways disease, and a further 372 
subjects had fulfilled the World Health Organi- 
zation (WHO) criteria (19) for chronic bronchitis 
in 1986. One hundred and twenty-eight subjects 
did not fulfil the temporal criteria for chronic 
bronchitis completely, but they had reported 
long-standing cough and sputum production. 
The reference group consisted of 625 subjects 
who, in the 1986 study, were not diagnosed as 
having either asthma or chronic bronchitis, or 
had not reported long-standing cough or sputum 
production. The study population and the par- 
ticipants in the postal questionnaire study are 
shown in Table 1. 
METHODS 
A postal questionnaire regarding respiratory 
symptoms and diseases, use of anti-asthmatic 
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TABLE 2. Distribution of respiratory symptoms in percent by sex and age in the bronchitic group (B) and the 
reference group (R), and differences in sex, age and smoking habits (P values) / 
Differences in 
M F All Sex Age Smoking habits 
Recurrent B 52.3 55.0 53.3 0.59 0.75 0.00 1 
wheeze R 10.8 8.0 9.8 0.30 0.60 0.05 
Attacks of B 34.1 45.0 38.2 0.02 0.39 0.54 
breathlessness R 8.2 8.0 8.1 0.95 0.22 0.83 
Long-standing B 44.8 55.6 48.9 0.03 0.38 0.04 
cough R 10.5 18.7 13.4 0.008 0.05 0.15 
Sputum B 69.5 70.2 69.8 0.89 0.16 0.60 
production R 19.3 15.0 17.8 0.21 0.81 0.35 
At least one B 79.9 81.3 80.4 0.73 0.08 0.50 
symptom R 27.2 24.6 26.3 0.52 0.79 0.33 
At least two B 61.3 70.8 64.9 0.04 0.43 0.80 
symptoms R 13.2 13.4 13.2 0.95 0.60 0.38 
At least three B 40.1 45.6 42.2 0.26 0.75 0.27 
symptoms R 4.4 8.0 7,4 0.67 0.89 0.40 
All four B 19.4 28.1 22.7 0.03 0.56 0.36 
symptoms R 1.5 3.7 2.3 0.09 0.88 0.90 
drugs, smoking habits and profession (16,18) 
was sent to 1148 subjects in 1991. In the ques- 
tionnaire, the following questions were added: 
(1) Do you snore so much that you think it is a 
problem? 
(2) Have relatives expressed worry about you 
stopping breathing while you are asleep? 
(3) Do you feel completely rested after a full 
night’s sleep? 
(4) Do you ‘nod off’ during breaks in daytime 
activities? 
In the Results and the tables, Question 3 is 
reported in an inverse way. The percentages are 
given for those who were not rested. 
PARTICIPANTS 
In the bronchitic group, 450 subjects (86%) out 
of 523 participated. The corresponding figures 
in the reference group were 529 (85%) out of 
625. There were no differences in the partici- 
pation rates between the different age groups 
and between the sexes. 
ANALYSIS 
Statistical analyses were performed by using 
Statistical Package for Social Sciences (SPSS). 
Bivariate comparisons were performed by Chi- 
square test and one way analysis of variance 
(ANOVA). 
Symptoms related to sleep disorders are 
expressed: 
(lj 
(2) 
As crude prevalence rates in the bronchitic 
and the reference groups, respectively; and 
In relation to age, sex, smoking habits and 
respiratory symptoms. 
Results 
PREVALENCE RATES OF RESPIRATORY 
SYMPTOMS 
Table 2 shows the distribution of respiratory 
symptoms by age and sex in the bronchitic and 
the reference groups, respectively. The most 
common respiratory symptom in both groups 
reported by the self-administered postal ques- 
tionnaire was sputum production, which was 
reported by 70% in the bronchitic group and 
18% in the reference group. Recurrent wheeze 
was reported by 53% in the bronchitic group 
and 10% in the reference group. The corre- 
sponding figures for long-standing cough were 
49 and 13%; and for attacks of breathlessness, 
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38 and 8%, respectively. The prevalences of the 
symptoms were similar in the age groups and 
sexes with the exception of long-standing 
cough, which was significantly more common 
in women. Only recurrent wheeze was strongly 
associated with smoking. 
At least one of the respiratory symptoms was 
reported by 80% in the bronchitic group and 
26% in the reference group. All four symptoms 
were reported by 28% of the women and 18% of 
the men (P=O*O3) in the bronchitic group. In the 
reference group, the corresponding figures were 
4 and 2%, respectively (P=O*O9). 
PREVALENCE RATES OF SYMPTOMS RELATED 
TO SLEEP DISTURBANCE 
Prevalence rates of symptoms related to sleep 
disturbances are shown in Table 3. ‘Not rested’ 
was the most common symptom associated 
with a sleep disorder. The symptom was 
reported equally in both men and women, and 
in the bronchitic (32%) and the reference 
groups (28%). The three other symptoms were 
all significantly more common in the bronchitic 
group and also significantly more common in 
men. In the bronchitic group, snoring was 
reported by 23%, apnoea by 18% and ‘nodding 
off’ by 16%. ‘Nodding off’ was more common 
in the elderly, and snoring was more common 
in the youngest age group, while the other 
symptoms were not obviously dependent on 
age in these adult age groups. Apnoea occurred 
more often in smokers, while the other symp- 
toms were not associated with smoking, except 
for snoring in the reference group but not in 
the bronchitic group. All four symptoms of 
sleep disturbances were more common in the 
subjects who also had recurrent wheeze, 
attacks of breathlessness, long-standing cough 
or sputum production (Table 4). 
INTER-RELATIONSHIPS BETWEEN SYMPTOMS 
OF SLEEP DISORDERS 
The inter-relationships between the four symp- 
toms of sleep disorders regardless of sex are 
reported in Table 5. All four symptoms were 
reported by 1.8% in the bronchitic group com- 
pared with 0.8% in the reference group. The 
most prevalent combination of at least three of 
the four symptoms was snoring, apnoea and ‘not 
TABLE 3. Distribution of sleep disturbances in percent by sex and age in the bronchitic group (B) and the reference 
group (R), and differences in sex, age and smoking habits (P values) 
1919-20 1934-35 1949-50 
(71-72 years) (56-57 years) (41-42 years) All Differences in 
Group M F M F M F M F All Sex Age Smoking 
Snoring B 19.8 9.4 36.5 17.5 30.2 15.9 29.0 14.0 23.3 <O.OOl 0.008 0.750 
R 7.8 10.5 23.7 3.5 10.7 9.1 13.7 8.0 11.7 0.051 0.032 0.019 
Apnoeas B 18.8 6.3 33.0 9.5 22.2 2,3 25.4 6.4 18.2 <O.OOl 0.015 0.046 
R 8.5 2,3 14.9 3.5 9.3 6.8 10.8 3.7 8.3 0.005 0.217 0.046 
Not rested B 30.7 35.9 32.2 28.6 36.5 29.5 32.6 31.6 32.2 0.819 0.878 0.468 
R 20.9 24.4 33.3 35.1 32.0 25.0 27.5 27.8 27.6 0.937 0.028 0.863 
Nodding off B 21.8 21.9 22.6 6.3 4.8 11.4 18.3 13.5 16.4 0.180 0.007 0.339 
R 7.8 4.7 11.4 3.5 5.3 4.5 8.5 4.3 7.0 0.070 0.459 0.980 
At least one B 58.4 54.7 60.9 39.7 54.0 38.6 58.4 45.0 53.3 0.324 0.005 0.741 
symptom R 34.0 34.9 48.2 38.6 41.3 36.4 40.4 36.4 38.9 0.089 0.369 0.764 
At least two B 19.8 14.1 40.9 14.3 23.8 18.2 29.4 15.2 24.0 0.008 <O.OOl 0.176 
symptoms R 8.5 5.8 21.9 7.0 9.3 6.8 13.2 6.4 10.8 0.006 0.016 0.005 
At least three B 9.9 3.1 17.4 6.3 15.9 2.3 14.3 4.1 10.4 0.171 <O.OOl 0.502 
symptoms R 2.6 1.2 7.9 0.0 4.0 2.3 4.7 1.1 3.4 0.218 0.028 0.074 
All four B 1.0 0.0 5.2 1.6 0.0 0.0 2.5 0.6 1.8 0.018 0.134 0.726 
symptoms R 0.0 0.0 1.8 0.0 1.8 0.0 2.7 0.0 0.8 0.168 0.138 0.634 
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TABLE 4. Relationships between respiratory symptoms in percent and symptoms express- 
ing sleep disturbances 
Snoring Apnoeas Not rested Nodding off 
Group Answer Yes Yes Yes Yes 
Recurrent B Yes 29.2 21.3 35.0 20.4 
wheezing No 17.5 15.3 25.7 10.4 
R Yes 28.8 13.5 26.9 21.2 
No 10.0 7.1 27.7 5.2 
Attacks of B Yes 26.2 23.3 38.4 19.8 
breathlessness No 20.6 15.0 27.5 12.1 
R Yes 23.3 14.0 27.9 18.6 
No 10.6 7.9 27.9 5.7 
Long-standing B Yes 29.1 22.3 35.9 18.6 
cough No 18.2 15.1 28.6 12.0 
R Yes 11.3 14.1 29.6 11.3 
No 11.8 7.4 27.8 5.3 
Sputum B Yes 26.1 19.4 34.4 18.5 
production No 15.3 15.3 26.3 9.3 
R Yes 19.1 13.8 29.8 16.0 
No 10.2 7.0 27.4 4.6 
B, bronchitic group; R, reference group 
rested’, which occurred in 6.0% the bronchitic 
group vs. 2.5% in the reference group. The most 
common combination of two symptoms in both 
the bronchitic and the reference groups was 
snoring and apnoea. Combinations of symptoms 
of sleep disorders were generally more common 
in men than in women. The most common 
combination of three symptoms was snoring, 
‘not rested’ and ‘nodding off’, which occurred in 
4.3% of men and 2.3% of women. 
Discussion 
The results suggest that snoring symptoms 
related to obstructive sleep apnoea occur more 
frequently in bronchitic subjects. In the bron- 
chitic group, 20% of those who were found to 
have chronic bronchitis or long-standing pro- 
ductive cough in 1986 did not report bronchitic 
symptoms in the present study. Others have 
found that about 20% of subjects in a clinical 
examination with chronic bronchitis (according 
to WHO criteria, 19) do not report symptoms in 
a postal questionnaire survey (17,20). It is poss- 
ible that this partly explains why not all of the 
subjects in the bronchitic group reported bron- 
chitic symptoms. On the other hand, 26% of 
subjects in the reference group, who were exam- 
ined and found to be healthy in the 1986 study, 
reported at least one bronchitic symptom in the 
present study. This indicates a high incidence of 
bronchitic symptoms. Both of these aspects may 
influence the internal validity of the results but, 
regardless of cohort, snoring and other OSAS 
symptoms were more common among those who 
reported any of the various bronchitic symp- 
toms, and OSAS symptoms were related to 
reported number of bronchitic symptoms. It is 
not possible to identify the subjects with COPD 
in a postal questionnaire study; however, high 
prevalences of OSAS symptoms were reported 
by the subjects with different bronchitic symp- 
toms. Those with bronchitic symptoms in 1986, 
and thus probably more long-standing symp- 
toms, tended to express snoring and other 
OSAS-related symptoms more frequently than 
those who reported bronchitic symptoms at this 
later study alone. 
The authors believe that the questions about 
snoring and apnoeas are related to obstructive 
sleep apnoea or to upper airway resistance syn- 
drome (UARS), and that they are more specific 
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TABLE 5. The inter-relationships in percent between the different symptoms of sleep 
disorders regardless of gender in the bronchitic group (B) and the reference group (R), and 
the proportions of subjects having at least three symptoms 
Independent variables 
Dependent variables 
Group Snoring Apnoeas Not rested Nodding off 
Snoring 
Apnoeas 
Not rested 
Nodding off 
B 100 49.5 45.7 29.5 
R 100 38.7 41.9 21.0 
B 634 100 47.6 26.8 
R 54.5 100 50.0 18.2 
B 33.1 26.9 100 24.1 
R 17.8 15.1 100 10.3 
B 41.9 29.7 47.3 100 
R 35.1 21.6 40.5 100 
Combinations of symptoms Group % 
Snoring, apnoeas, not rested and nodding off B 1.8 
R 0.8 
Snoring, apnoeas and not rested B 6.0 
R 2.5 
Snoring apnoeas and nodding off B 3.6 
R 1.3 
Snoring, not rested and nodding off B 3.6 
R 1.3 
Apnoeas, not rested and nodding off B 2.7 
R 0.8 
Results are expressed as percents. 
than the questions about daytime sleepiness, 
which could partly be due to sleep disturbances 
of other origins. The assumption was that none 
of the questions were convincing of OSAS, but 
that subjects with OSAS or UARS to a high 
degree would have a problem with snoring and 
probably some of the other symptoms. It is not 
known whether any combination of symptoms is 
more close to the diagnosis of OSAS than snor- 
ing alone, and sleep studies are required to reveal 
this. The authors had not expected apnoeas 
without a problem with snoring to be reported 
by so many subjects. Perhaps relatives are used 
to snoring, it is at least a life sign, but apnoeas 
are much more life-threatening. Central apnoeas 
could be another explanation. As expected, the 
most common symptom was to be unrested after 
a full night’s sleep. Bronchitic symptoms such as 
cough and sputum production may result in 
sleeping disturbances that could contribute to 
general daytime tiredness (l-4). Other symptoms 
related to OSAS such as snoring, apnoea and 
liability to ‘nod off’ during activity were more 
common among those with bronchitic symptoms 
compared to healthy subjects, although such a 
great difference was not anticipated. 
The strongest inter-relationships between 
OSAS symptoms were between snoring and 
apnoea. However, it is surprising that of those 
who expressed concern about apnoea, only 37% 
in the bronchitic group and 45% in the reference 
group expressed a problem with snoring. 
Snoring and apnoea were reported more 
commonly in men and this agrees with findings 
in other studies (12,13). As expected, these 
symptoms were related to age, and were most 
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common in the middle age group (born 1934- 
35) in both sexes. The age dependency is not 
clearly understood but it is possible that a 
higher mortality rate among those with OSAS 
could partly contribute to these findings (21). 
Another possible explanation is that more older 
subjects live alone and are unaware of their 
snoring or apnoea. 
Liability to unwillingly ‘nod off’ did not vary 
with sex but was less common in the youngest 
age group among the bronchitic subjects. This 
was not seen in the healthy group and it is 
possible that bronchitic symptoms result in 
sleep disturbances that contribute to tiredness. 
Some studies have found that smoking is a 
factor associated with snoring and other OSAS 
symptoms (9). Smoking in the bronchitic group 
is probably a biased factor and it may not be 
possible to estimate its influence in the present 
study. 
It is possible that bronchitic symptoms lead- 
ing to sleep disturbances influence and aggra- 
vate the experience of symptoms such as 
snoring, apnoea and various forms of tiredness 
assessed in the postal questionnaire. However, 
this study indicates a positive correlation 
between chronic bronchitis and sleep distur- 
bances. This correlation is likely to be 
explained by the combination of sputum pro- 
duction and upper airway swelling in subjects 
with chronic bronchitis. The majority of those 
with bronchitic symptoms have lower FEV, 
readings (18) but it is not known if obstruc- 
tive lung function impairment contributes to 
the high prevalence of OSAS symptoms in 
subjects with chronic bronchitis. Sleep studies 
are needed to ascertain whether the results of 
this study really represent a higher preva- 
lence of OSAS among subjects with bronchitic 
symptoms. 
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